The Glomerular Disease Study & Trial Consortium (GlomCon) aims to bring together clinicians, pathologists, researchers, and biotech innovators to create a scalable network of stakeholders interested in helping patients with glomerular kidney disease. Through this network of collaborations GlomCon aims to make the collective expertise of its members available for discussion of individual cases, provide infrastructure for biomarker studies, enable genomic research, and facilitate clinical trials.